Unichem Laboratories (UNICHEMLAB) | Stock Overview & Key Data
Unichem Laboratories Performance Comparison
Stock Range
Today's Range
Low: ₹495.00
High: ₹525.00
on August 8, 2025
52 Week Range
Low: ₹495.00
High: ₹937.95
on August 8, 2025
on November 8, 2024
All-Time High: ₹937.95 on November 4, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR38.0B
EPS
18.05
P/E Ratio (TTM)
29.89
Forward P/E
N/A
P/B Ratio
1.55
PEG Ratio
-0.10
Div. Yield
N/A
ROE
5.63%
Beta
-0.150
Debt to Equity
18.76
Financial Highlights
Profitability
Gross Margin
54.94%
Operating Margin
9.20%
Profit Margin
6.52%
Returns and Earnings
Return on Assets (TTM)
2.56%
Return on Equity (TTM)
5.63%
EBITDA
INR3.1B
Net Income (TTM)
INR1.4B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR299.83
Quarterly Revenue Growth (YoY)
14.70%
Quarterly Earnings Growth (YoY)
52.82%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Unichem Laboratories UNICHEMLAB | 37.99B Small-cap | -18.02% | -16.88% | -9.82% | -30.29% | -32.29% | -10.91% | 77.11% | 100.83% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | -2.63% | -5.12% | -10.20% | -8.38% | -16.03% | -8.55% | 73.73% | 198.65% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -7.03% | -14.75% | -0.77% | -0.41% | -2.61% | 22.45% | 58.73% | 91.42% |
| Sun Pharma Advanced SPARC | 48.23B Small-cap | -4.83% | -8.86% | 0.02% | -8.70% | -28.94% | -34.79% | -34.46% | -20.13% |
| Aarti Drugs AARTIDRUGS | 44.83B Small-cap | 0.47% | 3.52% | 17.71% | 21.40% | 7.96% | -1.73% | 18.09% | -4.28% |
| Sequent Scientific SEQUENT | 44.76B Small-cap | -0.34% | -9.41% | 8.30% | 7.32% | -9.00% | 22.29% | 57.12% | 26.68% |
Ownership & Short Interest
Insider Ownership
71.28%
Institutional Ownership
10.23%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
71K
Average 90-Day Volume
65K
Unichem Laboratories Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Unichem Laboratories would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is UNICHEMLAB's 52-week high and low?
- In the last 52 weeks, Unichem Laboratories reached a high of ₹937.95 (on November 8, 2024) and a low of ₹495.00 (on August 8, 2025).
- What is the market cap and P/E ratio for UNICHEMLAB?
- Curious about Unichem Laboratories's size and valuation? Its market capitalization stands at 37.99B. When it comes to valuation, the P/E ratio (trailing twelve months) is 29.89, and the forward P/E (looking ahead) is N/A.
- Does UNICHEMLAB pay dividends? If so, what's the yield?
- As for dividends, Unichem Laboratories isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Unichem Laboratories's main competitors or similar companies to consider before investing?
When looking at Unichem Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -8.55% 73.73% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 22.45% 58.73% Sun Pharma Advanced
SPARC48.23B Healthcare Drug Manufacturers - Specialty & Generic -34.79% -34.46% Aarti Drugs
AARTIDRUGS44.83B Healthcare Drug Manufacturers - Specialty & Generic -1.73% 18.09% Sequent Scientific
SEQUENT44.76B Healthcare Drug Manufacturers - Specialty & Generic 22.29% 57.12% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Unichem Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Unichem Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.63%, the Debt to Equity ratio from the most recent quarter is 18.76, and its Gross Profit Margin stands at 54.94%.
- What is the recent revenue and earnings growth for UNICHEMLAB?
- Looking at Unichem Laboratories's growth, its revenue over the trailing twelve months (TTM) was INR21B. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.70%, and quarterly earnings saw a YoY growth of 52.82%.
- How much of UNICHEMLAB stock is held by insiders and institutions?
- Wondering who owns Unichem Laboratories stock? Company insiders (like executives and directors) hold about 71.28% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 10.23%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.